AB Volvo (publ)
VLVLY News Today: Stay Updated with the Latest AB Volvo (publ) News in Real Time
Find VLVLY news now at Meyka AI. Stay informed with the latest AB Volvo (publ) stocks updates, including price news, market analysis, and expert insights.
XVIPY $6.54 Xvivo Perfusion AB (PNK) 13 Mar 2026: oversold bounce, watch $8.00 target
XVIPY stock at $6.54 shows an oversold bounce on 13 Mar 2026; Meyka AI forecast 1-year $9.58, implied upside 46.48%
Pre-market volume spike: 8072.T Japan Publ. Trading (JPX) 11 Mar 2026 orders
Pre-market volume spike on 8072.T stock at JPY 3980; we review flows, valuation, and Meyka AI’s forecast
GreenMerc AB (L5L.F) XETRA rises 20.65% intraday 09 Mar 2026: short-term outlook
Intraday: L5L.F stock up 20.65% at €0.33 on XETRA 09 Mar 2026. Meyka AI analysis and forecast
Volvo Cars Sales Decline Amid U.S. Tariffs as EV Segment Shows Strength
We at Auto Trends Insight have been watching recent developments at Volvo Cars closely. The Swedish automaker has reported a notable drop in overall sales this year. This decline comes in the face of ongoing global trade challenges, especially U.S. tariffs that have hit European carmakers hard. Yet there’s a silver lining: Volvo’s electric vehicle…
Tesla Boosts Market Share in France and Norway in February
Tesla continued its global momentum in February by increasing its market share in two key European electric vehicle markets: France and Norway. The company showed strong sales growth as demand for electric vehicles (EVs) remained high, even amid broader economic challenges. Market analysts watching electric car trends and the stock market took notice as Tesla’s…
Barclays keeps Overweight on Sandvik AB (publ) SDVKY; PT SEK 400 Feb 2026
SDVKY analyst rating: Barclays maintains Overweight and raises PT to SEK 400 on Feb 25, 2026
Citi Maintains Neutral on HNNMY (H & M Hennes & Mauritz AB) Feb 25, 2026
Citi maintains Neutral on HNNMY analyst rating, raises price target to SEK 174 on Feb 25, 2026
Morgan Stanley Maintains Underweight on Boliden AB (publ) BDNNY Feb 25 2026
Morgan Stanley kept Underweight and raised the price target for Boliden; BDNNY analyst rating, implications, and Meyka Grade B+
Barclays Maintains Overweight on BIOVF Swedish Orphan Biovitrum Feb 2026
Barclays maintained Overweight on BIOVF with a higher SEK 470 price target in Feb 2026; BIOVF analyst rating coverage explained